Notice2021-21799
Notice of Public Meeting of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 6, 2021
Issuing agencies
State Department
Abstract
In accordance with the Federal Advisory Committee Act, the U.S. Department of State announces that the PEPFAR Scientific Advisory Board (SAB) will be holding a virtual meeting of the full board. The meeting will be open to the public; a public comment session will be held during the meeting. Pre-registration is required for both public participation and comment.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 191 (Wednesday, October 6, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 191 (Wednesday, October 6, 2021)]
[Notices]
[Page 55678]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-21799]
[[Page 55678]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF STATE
[Public Notice: 11556]
Notice of Public Meeting of the U.S. President's Emergency Plan
for AIDS Relief (PEPFAR) Scientific Advisory Board
SUMMARY: In accordance with the Federal Advisory Committee Act, the
U.S. Department of State announces that the PEPFAR Scientific Advisory
Board (SAB) will be holding a virtual meeting of the full board. The
meeting will be open to the public; a public comment session will be
held during the meeting. Pre-registration is required for both public
participation and comment.
DATES: The meeting will be held virtually on Tuesday, November 2, 2021,
from approximately 10:00 a.m. to 2:00 p.m. (ET) and on Wednesday,
November 3, 2021, from approximately 10:00 a.m. to 2:00 p.m. (ET)
utilizing an online technology platform. Requests to attend the meeting
must be received no later than October 25, 2021. Requests for
reasonable accommodations or to provide public comment must be received
no later than October 25, 2021.
ADDRESSES: The meeting will be held virtually via an online platform.
Individuals are asked to pre-register at PEPFARSAB. The agenda be sent
to all registrants and will also be posted on the PEPFAR SAB web page
at <a href="http://www.state.gov/scientific-advisory-board-pepfar">www.state.gov/scientific-advisory-board-pepfar</a> one week in advance
of the meeting, along with instructions on how to access the meeting.
FOR FURTHER INFORMATION CONTACT: Dr. Sara Klucking, Designated Federal
Officer for the SAB, Office of the U.S. Global AIDS Coordinator and
Health Diplomacy at <a href="/cdn-cgi/l/email-protection#91dafde4f2faf8fff6c2c3d1e2e5f0e5f4bff6fee7"><span class="__cf_email__" data-cfemail="bef5d2cbddd5d7d0d9edecfecdcadfcadb90d9d1c8">[email protected]</span></a> or (202) 615-4350.
SUPPLEMENTARY INFORMATION:
Background: The SAB is established under the general authority of
the Secretary of State and the Department of State (``the Department'')
as set forth in 22 U.S.C. 2656, and consistent with the Federal
Advisory Committee Act, as amended (5 U.S.C. Appendix). The SAB serves
the U.S. Global AIDS Coordinator solely in an advisory capacity
concerning scientific, implementation, and policy issues related to the
global response to HIV/AIDS.
Agenda: SAB members will be discussing the COVID-19 pandemic and
its impact on people living with or at risk of HIV infection; PEPFAR
2020 and 2021 strategies, plans, programs and performance; PEPFAR 2022
strategic updates and Minimum Program Requirements; and PEPFAR
technical updates for 2022 including:
<bullet> Use of HIV self-testing to monitor HIV seroconversion in
persons taking pre-exposure prophylaxis (PrEP);
<bullet> implementation of HPV DNA testing as a primary screening
method for cervical cancer;
<bullet> new monitoring, evaluation and reporting (MER) indicators;
<bullet> use of point of care diagnostics and multiplex use of lab
instruments;
<bullet> updates on mortality-healthy living with HIV;
<bullet> addressing key gaps (AGYW, key populations, children).
Registered members of the public will be permitted to participate
in a comment period at the end of the meeting in accordance with the
Chair's instructions.
Public Participation: Members of the public who wish to participate
are asked to register directly at the link listed in the ADDRESSES
section or by sending an email to Ms. Crystal Solomon at
<a href="/cdn-cgi/l/email-protection#e2b18d8e8d8f8d8ca1a6a29196839687cc858d94"><span class="__cf_email__" data-cfemail="7d2e1211121012133e393d0e091c0918531a120b">[email protected]</span></a> not later than October 25, 2021. Individuals are
required to provide their name, email address, and organization. At
registration, individuals are also asked to indicate any request for
reasonable accommodation and/or a request to provide public comment.
Time for public comment may be limited. Requests made after October 25,
2021, will be considered but might not be able to be fulfilled.
Sara Klucking,
Director, Office of Research and Science, Office of the U.S. Global
AIDS Coordinator and Health Diplomacy, Office of the Secretary of
State.
[FR Doc. 2021-21799 Filed 10-5-21; 8:45 am]
BILLING CODE 4710-10-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 6, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.